Volver a Agendas
Session Chair(s)
Bingming Yi
Director
GSK, China
Speaker(s)
Maximizing Return on Investment in Designing Phase II Clinical Trials
Cong Chen, PHD
Merck & Co., Inc., United States
Director
A Bayesian prediction model between biomarker and clinical endpoint for dichotomous variables
Yang Song
MSD, China
Sr. Prin. Scientist, Biostatistics
A case study for a Bayesian approach to the assessment of safety for biosimilar and its application to bridging study (CN&EN)
Jerry Wang
Pfizer, United States
¿Tiene una cuenta?